Blog
Enavatuzumab: Revolutionizing Cancer Research Through Novel Therapeutics
Quick Facts About EnavatuzumabWhat is Enavatuzumab?Enavatuzumab is a monoclonal antibody targeting the TWEAK receptor (Fn14), pivotal in tumor growth and immune regulation.What is the me
…
17th Dec 2025
Alemtuzumab: Mechanism, Applications, and Biosimilar Advancements
Quick Facts About AlemtuzumabWhat is Alemtuzumab?Alemtuzumab is a monoclonal antibody targeting CD52, primarily used in the treatment of multiple sclerosis (MS) and certain cancers like
…
17th Dec 2025
3D Organoid Cell Viability Assay: Assessing Environmental Stress on BENOs for Live Delivery
Validation DataWhite PaperAuthors | Davide Ibatici & Anna Westhoff | Products: 3D Organoid Cell Viability Assay (AKES081)ObjectiveTo explore the possibility of de
…
19th Feb 2025
3D Organoid Cell Viability Assay: Performance Assessment in Human Colon Organoids
Validation DataWhite PaperAuthors | Nicolas Aznar, PhD & Laetitia Gerossier, PhD | SFR Biosciences Lyon & 3D B.I.O. Platform | Products: 3D Organoid Cell
…
19th Feb 2025
Comparison of Assay Genie Dual Luciferase Reporter Assay (MORV0010) vs Promega (E1910): Performance Evaluation of Quenching Efficiency and Auto-luminescence
Validation DataWhite PaperAuthor | Colm Ryan PhD | Products: Dual Luciferase Reporter Assay Kit (MORV0010)IntroductionThe Assay Genie Dual Luciferase Reporter Assay Kit is a robust and ec
…
17th Feb 2025
Compatibility and Performance Assessment of the GenieColor Mycoplasma Detection Kit Across Diverse Laboratory Conditions
Validation DataWhite PaperAuthor | Colm Ryan PhD | Products: GenieColor Mycoplasma Detection Kit (MORV0013)1. IntroductionThe GenieColor Mycoplasma Detection kit (MORV0013) is a rap
…
17th Feb 2025
3D Respiratory Organoids Cell Viability in a High-throughput 384-well Plate Assay
Validation DataWhite PaperAuthor | Dr Elodie Alessandri-Gradt | Department of Virology | UMR 1311 DYNAMICUREIntroductionAirway infection is the 4th leading cause of death world
…
17th Feb 2025
Automation of MR-proANP and MR-proADM ELISA Kits on Dynex DS2 Instrument
Validation Data White Paper Author | Colm Ryan, PhD | Products: MR-proANP ELISA Kit & MR-proADM ELISA Kit Introduction The Assay Genie MR-proANP (Mid-Re
…
17th Feb 2025
Tinurilimab: Advancing Immunotherapy Through CD47 Blockade
Quick Facts About TinurilimabWhat is Tinurilimab?Tinurilimab is a monoclonal antibody targeting CD47, a protein that cancer cells use to evade immune system attack. By blocking CD47, Tin
…
11th Feb 2025
Indusatumab: Advancing Anti-CD47 Cancer Research with Biosimilar Innovations
Quick Facts About IndusatumabWhat is Indusatumab?Indusatumab is an experimental antibody therapy targeting CD47, a protein that enables cancer cells to evade immune destruction.How does
…
8th Feb 2025
Crizanlizumab: A Comprehensive Overview of Its Role in Sickle Cell Disease and Ongoing Research
Quick Facts About CrizanlizumabWhat is Crizanlizumab?Crizanlizumab is a monoclonal antibody used to treat sickle cell disease by targeting P-selectin, a protein involved in inflammation
…
7th Feb 2025
Unveiling Prezalumab: Targeting the Role of Anti-CD47 in Cancer Immunotherapy
What You Need to Know About PrezalumabWhat is Prezalumab?Prezalumab is a monoclonal antibody designed to target CD47, a protein often overexpressed in cancer cells to evade immune detect
…
6th Feb 2025
Alsevalimab: Targeting CD47 for Cancer Research and Treatment
Quick Facts About AlsevalimabWhat is Alsevalimab?Alsevalimab is a monoclonal antibody targeting CD47, a protein involved in immune evasion by cancer cells. By blocking CD47, Alsevalimab
…
6th Feb 2025
Lemzoparlimab: Targeting CD47 for Cancer Immunotherapy Advancements
Quick Facts About LemzoparlimabWhat is Lemzoparlimab?Lemzoparlimab is a monoclonal antibody that targets CD47, a protein known for its role in helping tumors evade the immune system. By
…
6th Feb 2025
Zilovertamab: Unlocking the Potential of ROR1-Targeted Therapy
Quick Facts About ZilovertamabWhat is Zilovertamab?Zilovertamab is a monoclonal antibody targeting ROR1, a receptor tyrosine kinase overexpressed in hematologic cancers and solid tumors.
…
6th Feb 2025
Rovalpituzumab Tesirine: Advancing Small Cell Lung Cancer Research
Quick Facts About Rovalpituzumab TesirineWhat is Rovalpituzumab Tesirine?Rovalpituzumab Tesirine (Rova-T) is an antibody-drug conjugate (ADC) designed to target DLL3, a protein overexpre
…
6th Feb 2025
Trastuzumab: Revolutionizing HER2-Positive Cancer Treatment & Research
Quick Facts About TrastuzumabWhat is Trastuzumab?Trastuzumab is a monoclonal antibody used to treat HER2-positive breast and gastric cancers. It specifically targets the HER2 protein, re
…
6th Feb 2025
Unlocking the Potential of Anti-CD47 in Cancer Immunotherapy
Quick Facts About RagifilimabWhat is Ragifilimab?Ragifilimab is an investigational anti-CD47 monoclonal antibody developed to block the CD47-SIRPα interaction, thereby enhancing macropha
…
6th Feb 2025
Canakinumab: Unraveling Its Role in Inflammatory Disease and Cancer Research
Quick Facts About CanakinumabWhat is Canakinumab?Canakinumab is a human monoclonal antibody that targets interleukin-1 beta (IL-1β), reducing inflammation associated with various disease
…
5th Feb 2025
Avdoralimab: Exploring Its Role in Immunotherapy and Biosimilar Advancements
Quick Facts About AvdoralimabWhat is Avdoralimab?Avdoralimab is a monoclonal antibody targeting C5aR1, playing a crucial role in modulating immune response and inflammation.What is the m
…
5th Feb 2025
Vesencumab: Unlocking the Potential of Anti-CD47 in Cancer Research
Quick Facts About VesencumabWhat is Vesencumab?Vesencumab is an experimental monoclonal antibody designed to target CD47, a key regulator of immune evasion in cancer cells.How Does Vesen
…
4th Feb 2025
Natalizumab: Mechanism, Applications, and Emerging Research in Multiple Sclerosis and Crohn's Disease
Quick Facts About NatalizumabWhat is Natalizumab?Natalizumab is a monoclonal antibody used to treat multiple sclerosis (MS) and Crohn's disease. It works by blocking immune cells from at
…
2nd Feb 2025
Denosumab: A Comprehensive Overview of Mechanism, Applications, and Research Advances
What You Need to Know About DenosumabWhat is Denosumab?Denosumab is a monoclonal antibody used primarily to treat osteoporosis and bone-related complications in cancer patients. It targe
…
2nd Feb 2025
Talquetamab: Exploring its Role in Cancer Therapy and Ongoing Research
Quick Info Section: Key Facts About TalquetamabWhat is Talquetamab?Talquetamab is a novel monoclonal antibody being developed for the treatment of multiple myeloma and other cancers. It
…
2nd Feb 2025